Dolby Laboratories (NYSE:DLB) Receives $92.00 Average Target Price from Analysts

Shares of Dolby Laboratories (NYSE:DLB) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is $92.00.

DLB has been the subject of several analyst reports. Tigress Financial raised their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a report on Friday, August 15th. Robert W. Baird began coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday. Barrington Research decreased their price target on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday. Finally, Baird R W raised Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th.

Insider Buying and Selling at Dolby Laboratories

In other news, CEO Kevin J. Yeaman sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at $7,901,110.75. This trade represents a 17.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 38.39% of the company’s stock.

Institutional Trading of Dolby Laboratories

Hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in Dolby Laboratories by 2.7% in the third quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after purchasing an additional 203,411 shares during the last quarter. State Street Corp lifted its holdings in shares of Dolby Laboratories by 8.7% in the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares during the period. AQR Capital Management LLC boosted its stake in shares of Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares during the last quarter. Geode Capital Management LLC grew its holdings in Dolby Laboratories by 2.0% during the second quarter. Geode Capital Management LLC now owns 1,556,571 shares of the electronics maker’s stock worth $116,159,000 after acquiring an additional 30,057 shares during the period. Finally, First Trust Advisors LP raised its position in Dolby Laboratories by 22.7% during the third quarter. First Trust Advisors LP now owns 1,518,657 shares of the electronics maker’s stock valued at $109,905,000 after acquiring an additional 281,214 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Price Performance

DLB stock opened at $67.52 on Thursday. The firm has a 50-day moving average of $68.59 and a 200 day moving average of $72.35. Dolby Laboratories has a 1 year low of $64.02 and a 1 year high of $89.66. The company has a market cap of $6.47 billion, a P/E ratio of 24.73 and a beta of 0.97.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to analyst estimates of $305.76 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company’s revenue for the quarter was up .7% on a year-over-year basis. During the same period last year, the company earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. On average, equities research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be given a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is currently 54.75%.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.